Management of internal carotid artery near-occlusion: the need for updated evidence

Constantine N Antonopoulos1, Alexandros Giosdekos1, Spyridon N Mylonas1,2

  • 1Athens Vascular Research Center, Athens, Greece.

Insights

Near internal carotid artery (ICA) occlusion carries a high stroke risk with best medical treatment (BMT). Carotid endarterectomy (CEA) and carotid artery stenting (CAS) appear safe and effective, with decreasing stroke rates over time.

Area of Science:

  • Vascular Surgery
  • Neurology
  • Interventional Cardiology

Background:

  • Near occlusion of the internal carotid artery (ICA) is a rare condition often misdiagnosed.
  • Treatment decisions for revascularization remain controversial.

Purpose of the Study:

  • To investigate outcomes of carotid endarterectomy (CEA), carotid artery stenting (CAS), and best medical treatment (BMT) for near-ICA occlusion.
  • To examine the influence of time on stroke rates associated with near-ICA occlusion.

Main Methods:

  • An updated meta-analysis of electronic health databases up to November 2019.
  • Calculation of pooled stroke rates for CEA, CAS, and BMT.
  • Investigation of transient ischemic attack (TIA), stroke-related death, myocardial infarction (MI), all-cause death, and restenosis rates.

Main Results:

  • Pooled stroke rates: CEA 1.52%, CAS 1.80%, BMT 8.39%.
  • CEA: 2.5% TIA, 3.7% all-cause death, 0.6% stroke death, 0.7% MI. CAS: 1.2% TIA, 9.3% all-cause death, 0.7% stroke death, 3.6% MI. BMT: 6.1% TIA, 3.8% all-cause death, 0% stroke death, 0% MI.
  • Restenosis rates: CEA 9.0%, CAS 4.1%. Stroke rates decreased significantly over time for CAS and BMT.

Conclusions:

  • Best medical treatment (BMT) alone for near-ICA occlusion is associated with a high stroke rate.
  • Interventional treatments (CEA and CAS) appear safe and effective for near-ICA occlusion.
  • A downward trend in stroke rates over time suggests improved management strategies for CAS and BMT.